The goal of the present experiments was to analyse the binding of oxytocin (OT) and vasopressin (VP) Specific neurohypophyseal hormone-binding sites have been characterized and localized in the brain using binding techniques to acellular preparations (for examples see 1-6) and/or autoradiography (for examples see 7-14). Two types of binding sites have thus been clearly defined, oxytocin (0T)-binding sites, which havc nanomolar-range affinity for O T and vasopressin (VP), and VP-binding sites, which have nanomolar-range affinity for VP and a much lower affinity for OT (3, 11). In the rat brain, the two types of sites have quite distinct distributions: OT-binding sites occur mainly in the ventral subiculum, several nuclei of the amygdala, the ventromedial hypothalamic nucleus, the bed nucleus of the stria terminalis and the olfactory tubercle (8-11, 13, 14); VP-binding sites are mainly detected in the nucleus of the solitary tract, several thalamic nuclei, the suprachiasmatic nucleus, the fundus striati and the lateral septa1 nucleus (7, 8, 10-13). The pharmacological characteristics (high affinity, low capacity, saturability) of the OT and VP sites detected in such locations (l-6), and their occurrence in areas where exogenous O T or VP can affect the electrical response of neurons (1 5-17), suggest that they are functional receptors.Binding of neurohypophyseal hormones has also been shown to occur in the hypothalamo-neurohypophyseal system, i.e. the supraoptic nuclei (SON), the paraventricular nuclei (PVN) and It is questionable whether receptors are involved in OT and VP binding in the hypothalamo-neurohypophyseal system. OT and VP may bind to neurophysins which are associated with these peptides in the secretory vesicles, scattered in the perikarya and the axons, and highly concentrated in the nerve endings in